Toxoplasma

Entry 1. Walking the Long Walk.

A decade ago, I finished my teaching gig with the middle school in New Haven. I started this research journey to unravel the connections between chronic brain parasitism and neurological diseases. This problem impacts over 2.5 billion humans infected with the brain parasite Toxoplasma.

I did not how to answer such a big and complex question. But, my middle-schoolers screamed in my dreams, “Dr. Ngô, are you walking the walk, or just talking the talk?” (see Biography). So, I closed my eyes and took a plunge of faith.

The classical training stuck with me from past biology mentors such as Drs. David F. Parmelee, Gerald W. Prescott, David B. Czarnecki, and Ben G. Bouck. A biologist explores as many factors of an ecosystem as possible. A scientist must examine as many components of a research problem as viable. You don't take shortcuts. You do things the right way!

I left behind that foundation to chase the leading edge of science. Success at Yale Medical School taught me to be more linear and focus only into a small piece of the puzzle.

My gut told me I needed both approaches, but more so of the ole school thinking, to solve this complex problem.

Since most of this work done was in the shadow of established research programs, I chronicled this personal journey. It breaks into eight entries so the reader won't fall asleep and bonk their head on the computer screen. I took an unconventional, difficult route ‘to do things the right way'. It needs narration. I need catharsis!


Summary of My Journey.

In 2006, I expected the following decades would be an argumentative debate between the Toxoplasma traditional camp and a smaller emerging group of incoming researchers.

The first group posited without proof a long-standing dogma. Chronic brain infection had no significant consequence unless the host is weakened from being immunocompromised. It's ‘harmless’. 

The second provided data and perspective linking chronic brain parasitism to other brain diseases such as schizophrenia. Epidemiology and serological surveys of the general population would start, but fail to carry convincing proof to the debate (see Brain Parasite Toxoplasma).

I bypassed this argument because the more logical dogma should have been: a eukaryotic organism living in the intricate brain of human host will have consequences. 

The right questions should be: Which brain diseases are linked to the chronic infection of a protozoan? How? And what we do about it?

I chose the strategy of concentrating on a human cohort with the infection. We could identify critical human gene networks leading to brain pathology. I chose also the ‘ecological’ approach. Studying the micro-ecosystem of a protozoan parasite living in the human brain requires an integration of major inputs/causes and outputs/effects. A more holistic approach was needed to study an infected human organ.

One could predict obvious trends and be at least a decade ahead of the pack and simply avoid competition.  This style of leapfrogging the pack has several major drawbacks. One is the lack of peer interaction and support. Second is the lack of institutional and financial support.

The current, protracted debate delay, or ignore, the most important question. How to solve the human disease problems? Hence, I built with a network of collaborators a platform of protein crystallographic structures (see Drug Discovery). The mission is find drugs to kill the brain parasite and to heal the neural damage.

The results are:

1. We decoded the neurological gene-protein network that may associate Toxoplasma brain parasitism to neural cancer, Alzheimer's disease, epilepsy and several movement disorders.

2. We built a base of protein crystallographic structures to use for future drug design in targeting the brain parasite.

The diagram below shows my map of this decade-long journey. It breaks into 3 periods.

Diagram 1. Huân's offbeat journey in developing the two-pronged strategy to find cures for brain parasitism and diseases.

The first phase is the one and half years spent working from my home. I learned basics of neurobiology. Then, I deep dived into an analysis of over 600 mammalian genes moderated by the parasite. The gene list assembled was based on studies published up to 2006.

I wrote a short document of my early “Neurocompromised Hypothesis”. It proposed that susceptible genetics compromise a human brain to Toxo parasitic effects, resulting in neuropathology. I did not publish this piece because the dataset was a largely artificial construct. We did not need more noises in the debate.

What emerged was my shift in the gene-environment paradigm. I changed it to gene-environment-development paradigm.

The second phase is my tour of scientific duty to Chicago armed with the new paradigm. I rebuilt my science network and laid the foundation for the 2-prong strategy of tackling brain parasitism (see Brain Parasite Toxoplasma).

For the last phase I was back at home. For 5 years, I deep-dived again into learning new sciences to solve the problem. I learned Neurobiology, Systems and Structural Biology while waiting for the grueling progress of my collaborators.

In 2015, I finally had proper datasets in hand. I took another deep-dive for seven months. I emerged with the Reconstruction and Deconvolution model. Most important is the satisfying maps likely linking Toxoplasma brain infection to cancer, epilepsy, Huntington’s and Alzheimer’s disease.

In 2017, an excessive version of my manuscript is published. The discoveries and thoughts from my home (see BrainMicro LLC) remain the meat of this publication (Diagram 2).

Diagram 2. Core paradigm and Reconstruction-Deconvolution of Toxoplasma brain infection.

Diagram 2. Core paradigm and Reconstruction-Deconvolution of Toxoplasma brain infection.


In future journal entries, I will discuss more in depth the roadblocks and my solutions to find cures for brain parasitism and diseases.

Journal Schedule

Entry 1. Walking the Long Walk, posted November 5, 2017.

Entry 7. A passionate plea to my colleagues, posted November 5, 2017.

___________________________

Entry 2. The Roadblocks, 2018.

Entry 3. Preparing for the Walk (2006-2007), 2018.

Entry 4. Scientific Tour of Duty (2007-2011), 2018.

Entry 5. Two-Pronged Counterinsurgency, 2018.

Entry 6. The Lost Art of ‘Synthesis’ (2011-2017), 2018.

Entry 8. I walked the walk less travelled, 2018.


Entry 7. A passionate plea to my colleagues

If I expect change, it must start with me.

I favor sharing and working together to benefit society and humanity (see Scientist).

After a decade of hard work and personal sacrifices, I wrapped my works into packages and e-mailed them to the Toxoplasma international research community (Figure 1).

I hope the works done will be used to find cures.

If I expect change, it must start with me. The email sent out is shown.

Figure 1. The packages of the two-pronged strategy and personal plea were emailed to an international network of research groups who have published works on Toxoplasma.


Subject:   Toxoplasma: Protein structure-functions and potential correlations with Brain Cancer, Epilepsy, Huntington’s and Alzheimer’s Diseases

Date:   August 2, 2017

From:    Huân M. Ngô, Ph.D.

Dear Colleague,

This communication provides the Toxoplasma research community a summary and opportunities from a research initiative.

1. The Questions.

I asked three basic questions. (1) What is the human brain gene network likely activated by the brain parasite Toxoplasma? (2) What are the neurological diseases correlated with brain parasitism? (3) What do we do about it?

2. The Progress.

A summary is described (now converted to Brain Parasite Toxoplasma page).

I answered Question 1 and 2 using a new paradigm. The ‘Gene-Environment’ paradigm changes to include a third component of ‘Development’. 

I constructed the ‘Reconstruction-Deconvolution’ Model to get the complex answers. Our template points to the potential modulation of human brain pathways correlating to Brain Cancer, Epilepsy, Huntington’s and Alzheimer’s Diseases.

For Question 3, we focus on the structure-based approach for discovery of drugs against the brain stage of parasites. We develop a protein structural platform for the Toxoplasma community. Our effort produced 12 crystallographic structures of Toxoplasma enzymes (Drug Discovery page). We hope it helps with functional studies and to develop drugs against Toxoplasma brain parasitism.

We examined the structure-function of two multifunctional enzymes (Enolase 1, GAPDH1) and a non-metabolic role of a pseudoenzyme (TgDPA). Enolase 1 and TgDPA are specific bradyzoite proteins.

GAPDH1 publication is one of the most complete protein structure-function studies to date. We used the molecular and biochemical repertoire (Dubey et al 2017).

3. Opportunities for Structure-Function Studies.

All 12 protein structures are open to the research community. We invite colleagues to use them to pursue (a) structure-functions and essentiality, and (b) compound screening for drug leads. See Doc 2 (Drug Discovery page) for additional details.

As far as we know, our collaborators for the 3 published structural studies have no further plans for these enzymes, but please check with them to avoid any conflicts. They are: (1) Bradyzoite pseudoaldolase (Dr. Martin Boulanger, U. of Victoria), (2) Enolase 1 (Dr. Stan Tomavo, U. de Lille), (3) GAPDH1 (Dr. Marc-Jan Gubbels, Boston College).

Only ornithine aminotransferase (PDB accession 5UPR) is being pursued further by Dr. Richard Silverman (Northwestern U.) with ligand studies and by Dr. Rima McLeod with cat stage studies. We encourage other researchers to pursue its structure-function with other biological experiments.

Please contact Dr. Wayne Anderson (CSGID) for information about clones and limited purified proteins. Dr. Anderson will retire August 31 of 2017. You can then contact the new Co-Director, Dr. Karla Satchell (k-satchell@northwestern.edu)

4. Opportunities for Neurological Disease Studies.

The proposed correlation between Toxoplasma brain parasitism and noted neurological diseases is a hypothesis that will require rigorous testing & critique from the research community (see Brain Parasite Toxoplasma page).

If proven true, the brain gene networks provide a starting point for further validation and therapeutic approaches.

I completed the Reconstruction-Deconvolution analysis in July of 2015. The manuscript has been entangled further in a web of politics. I hope it will be published soon in whatever form it takes.

I’m interested in advancing the community's evaluation of this hypothesis. We should advance finding cures for these devastating neurological diseases. As a colleague, you can request directly a copy of my last revision of this manuscript. You can judge for yourself the hypothesis and data.

5. The future

We have enjoyed over 4 decades of developing basic research of Toxoplasma as an interesting cellular, molecular and immunological model. Only within the last decade have we started to examine its neurobiological, endocrinological, and psychiatric bases.

I welcome the influx of researchers from outside of our classical parasitology training. I am encouraged by the increasing efforts from Asia, Middle East and South America to develop diagnostics, vaccines and drugs, which have been lackluster in North America and Europe.

I plead passionately to my colleagues that we need to re-shift our focus to finding cures for Toxoplasma brain parasitism and correlating brain diseases. Please think of our research as more than ‘it’s such an interesting organism to study’.

If proven true, we have the moral obligation to find drugs and vaccines for people suffering from Brain Cancer, Epilepsy, Alzheimer’s, Huntington’s Disease (and Schizophrenia).


Addendum. The Credentials

Since I don't follow the normal professional route and an unknown name to most people, I’m obliged to highlight several key contributions in parasitology. A CV will be attached.

* As a graduate student, I propose and wrote with my PhD advisor the novel synthesis of the membrane cytoskeletal motif in protozoans. We expanded his discovery of the articulins in Euglena to other free-living and parasitic relatives. It provided the base for the discovery of structural proteins in the Apicomplexan cortical skeleton, such as the IMCs.

       Bouck and Ngô, 1996, Int. Rev. Cytology 169: 267-318.

* As a postdoc at Yale, I synthesized the convergence of endocytic and secretory pathways in rhoptry biogenesis.

       Ngô et al., 2004, Molecular Microbiol 52:1531-41.

* In a serendipitous collaboration with a neighboring lab at Yale, Dr. Elisabetta Ullu and I discovered RNA interference in African trypanosome.

       Ngô et al., 1998, PNAS 95: 14687-14692.

After my postdoc, I left research to build a model science education program for our inner-city kids in New Haven, Connecticut.

The brain parasitism work mentioned above is from the last decade from which I learned new disciplines of neuroscience, structural and systems biology.

To bring this research initiative to this point, I worked out of my home in New Haven, USA. I depleted my own retirement fund to learn and work independently. Due to my cavalier attitude to my professional development, I cannot continue the normal research route.

I hope you can find your own resources to collaborate in pursuing these studies, such as a structural biology collaborator. If not, I would consider servicing as a consultant, but I emphasize that it’s NOT required. The projects are open to the community.

I hope this body of works provides a solid foundation for others to continue our common mission of finding cures for over 2 billions humans infected with brain parasitism.

Best regards,

Huân